Announcements
Sidley Represents Novo Holdings in a Growth Capital Investment in Oxford Nanopore Technologies
August 2, 2024
Sidley represented Novo Holdings, a leading international life science investor, on their £50 million investment in Oxford Nanopore Technologies, the leading UK-listed company behind a new generation of molecular sensing technology based on nanopores.
Novo Holdings will invest £50 million in Oxford Nanopore as part of an equity issue and intends to add to this investment over time, with further purchases in the secondary market subject to availability and price (among other factors).
The Sidley team was led by Private Equity partner Robert Darwin, supported by partner James Wood, counsel Ed Perry, and associate Jessica Edwards (M&A and Private Equity).
Novo Holdings will invest £50 million in Oxford Nanopore as part of an equity issue and intends to add to this investment over time, with further purchases in the secondary market subject to availability and price (among other factors).
The Sidley team was led by Private Equity partner Robert Darwin, supported by partner James Wood, counsel Ed Perry, and associate Jessica Edwards (M&A and Private Equity).
Contacts
Offices
Capabilities
Suggested News & Insights
Chambers Global Practice Guides – Corporate M&A 2026April 24, 2026Sidley Represents ModMed in Its Acquisition of Bonsai HealthApril 22, 2026Sidley Represents Cboe Global Markets in Its US$300 Million Sale of Cboe Australia and Cboe Canada to TMX GroupApril 22, 2026Sidley Represents Churchill Downs in Its Acquisition of Preakness Intellectual Property RightsApril 22, 2026Sidley Represents The Denver Post in Sale of Interest in Colorado RockiesApril 20, 2026Drinks With The Deal: Sidley’s Mehdi KhodadadApril 17, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory